PLSE
Price
$16.73
Change
+$0.79 (+4.96%)
Updated
Apr 2 closing price
Capitalization
481.01M
34 days until earnings call
QDEL
Price
$34.63
Change
+$0.52 (+1.52%)
Updated
Apr 2 closing price
Capitalization
3.14B
27 days until earnings call
Ad is loading...

PLSE vs QDEL

Header iconPLSE vs QDEL Comparison
Open Charts PLSE vs QDELBanner chart's image
Pulse Biosciences
Price$16.73
Change+$0.79 (+4.96%)
Volume$265.68K
Capitalization481.01M
QuidelOrtho
Price$34.63
Change+$0.52 (+1.52%)
Volume$434K
Capitalization3.14B
PLSE vs QDEL Comparison Chart
Loading...
PLSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QDEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PLSE vs. QDEL commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLSE is a Hold and QDEL is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (PLSE: $16.73 vs. QDEL: $34.63)
Brand notoriety: PLSE and QDEL are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: PLSE: 122% vs. QDEL: 51%
Market capitalization -- PLSE: $481.01M vs. QDEL: $3.14B
PLSE [@Medical Specialties] is valued at $481.01M. QDEL’s [@Medical Specialties] market capitalization is $3.14B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLSE’s FA Score shows that 0 FA rating(s) are green whileQDEL’s FA Score has 1 green FA rating(s).

  • PLSE’s FA Score: 0 green, 5 red.
  • QDEL’s FA Score: 1 green, 4 red.
According to our system of comparison, both PLSE and QDEL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLSE’s TA Score shows that 3 TA indicator(s) are bullish while QDEL’s TA Score has 5 bullish TA indicator(s).

  • PLSE’s TA Score: 3 bullish, 5 bearish.
  • QDEL’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, QDEL is a better buy in the short-term than PLSE.

Price Growth

PLSE (@Medical Specialties) experienced а +5.89% price change this week, while QDEL (@Medical Specialties) price change was -1.11% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.40%. For the same industry, the average monthly price growth was +3.95%, and the average quarterly price growth was +3.94%.

Reported Earning Dates

PLSE is expected to report earnings on May 07, 2025.

QDEL is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Medical Specialties (-1.40% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QDEL($3.14B) has a higher market cap than PLSE($481M). PLSE YTD gains are higher at: -3.906 vs. QDEL (-22.267). QDEL has higher annual earnings (EBITDA): 607M vs. PLSE (-42.37M). QDEL has more cash in the bank: 167M vs. PLSE (44.4M). PLSE has less debt than QDEL: PLSE (9.14M) vs QDEL (2.61B). QDEL has higher revenues than PLSE: QDEL (3B) vs PLSE (0).
PLSEQDELPLSE / QDEL
Capitalization481M3.14B15%
EBITDA-42.37M607M-7%
Gain YTD-3.906-22.26718%
P/E RatioN/A9.76-
Revenue03B-
Total Cash44.4M167M27%
Total Debt9.14M2.61B0%
FUNDAMENTALS RATINGS
PLSE vs QDEL: Fundamental Ratings
PLSE
QDEL
OUTLOOK RATING
1..100
528
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
57
Fair valued
PROFIT vs RISK RATING
1..100
78100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
4984
P/E GROWTH RATING
1..100
10013
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QDEL's Valuation (57) in the Medical Specialties industry is in the same range as PLSE (59). This means that QDEL’s stock grew similarly to PLSE’s over the last 12 months.

PLSE's Profit vs Risk Rating (78) in the Medical Specialties industry is in the same range as QDEL (100). This means that PLSE’s stock grew similarly to QDEL’s over the last 12 months.

QDEL's SMR Rating (97) in the Medical Specialties industry is in the same range as PLSE (98). This means that QDEL’s stock grew similarly to PLSE’s over the last 12 months.

PLSE's Price Growth Rating (49) in the Medical Specialties industry is somewhat better than the same rating for QDEL (84). This means that PLSE’s stock grew somewhat faster than QDEL’s over the last 12 months.

QDEL's P/E Growth Rating (13) in the Medical Specialties industry is significantly better than the same rating for PLSE (100). This means that QDEL’s stock grew significantly faster than PLSE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PLSEQDEL
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 1 day ago
69%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 1 day ago
64%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 1 day ago
76%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
70%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 8 days ago
79%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
79%
View a ticker or compare two or three
Ad is loading...
PLSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QDEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYMAX45.32N/A
N/A
Rydex Telecommunications H
MFRJX54.98N/A
N/A
MFS Research R4
GMNPX41.36N/A
N/A
Goldman Sachs MLP Energy Infras P
PEICX20.84N/A
N/A
PGIM Jennison Value C
MCGIX11.97N/A
N/A
AMG Montrusco Bolton Large Cap Growth I

PLSE and

Correlation & Price change

A.I.dvisor tells us that PLSE and CERS have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PLSE and CERS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLSE
1D Price
Change %
PLSE100%
+4.96%
CERS - PLSE
31%
Poorly correlated
+1.45%
IRMD - PLSE
31%
Poorly correlated
+0.28%
QDEL - PLSE
29%
Poorly correlated
+1.52%
SRTS - PLSE
26%
Poorly correlated
+6.57%
ICUI - PLSE
26%
Poorly correlated
+1.87%
More